The artificial lung market growth trajectory demonstrates remarkable momentum fueled by convergence of multiple healthcare trends including chronic respiratory disease burden escalation, technological innovation in biomedical engineering, and evolving clinical protocols expanding treatment eligibility criteria. Growth drivers encompass increasing awareness among pulmonologists and...